Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials
Hall Render
SEPTEMBER 14, 2023
Food and Drug Administration (“FDA”) released draft guidance regarding the conduct of decentralized clinical trials (“DCTs”) for drugs, biological products and devices. This draft guidance expands on previous FDA recommendations released in the midst of the COVID-19 pandemic.
Let's personalize your content